Authors: Anna Howard, Julia Kerr, Monica McLain, Jessie Modlin

Oral cancer treatment agents are being prescribed more frequently in many cancer types. In-office dispensing of oral cancer treatment agents has demonstrated clinical benefits and also shown financial benefit to third-party payers. A previous publication estimated over $200,000 in cost savings annually from in-office dispensing solely from medications returned to stock for credit. However, pharmacists in the in-office setting perform many other interventions that may affect financial outcomes. Read More.